rs375283810

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001009944.3(PKD1):​c.8161+12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000379 in 1,507,316 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 2 hom., cov: 20)
Exomes 𝑓: 0.00030 ( 5 hom. )

Consequence

PKD1
NM_001009944.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.673

Publications

0 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 16-2104486-G-A is Benign according to our data. Variant chr16-2104486-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00112 (166/148232) while in subpopulation AFR AF = 0.00335 (131/39160). AF 95% confidence interval is 0.00288. There are 2 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 20. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.8161+12C>T intron_variant Intron 22 of 45 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.8161+12C>T intron_variant Intron 22 of 45 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.00107
AC:
159
AN:
148118
Hom.:
2
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.00318
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000666
Gnomad ASJ
AF:
0.00290
Gnomad EAS
AF:
0.000812
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000119
Gnomad OTH
AF:
0.00146
GnomAD2 exomes
AF:
0.000441
AC:
67
AN:
151966
AF XY:
0.000412
show subpopulations
Gnomad AFR exome
AF:
0.00426
Gnomad AMR exome
AF:
0.0000788
Gnomad ASJ exome
AF:
0.00156
Gnomad EAS exome
AF:
0.0000828
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000686
GnomAD4 exome
AF:
0.000298
AC:
405
AN:
1359084
Hom.:
5
Cov.:
28
AF XY:
0.000296
AC XY:
199
AN XY:
673434
show subpopulations
African (AFR)
AF:
0.00458
AC:
137
AN:
29942
American (AMR)
AF:
0.000191
AC:
7
AN:
36614
Ashkenazi Jewish (ASJ)
AF:
0.00229
AC:
57
AN:
24882
East Asian (EAS)
AF:
0.000136
AC:
5
AN:
36718
South Asian (SAS)
AF:
0.000214
AC:
17
AN:
79304
European-Finnish (FIN)
AF:
0.0000237
AC:
1
AN:
42114
Middle Eastern (MID)
AF:
0.000746
AC:
3
AN:
4024
European-Non Finnish (NFE)
AF:
0.000136
AC:
143
AN:
1048872
Other (OTH)
AF:
0.000618
AC:
35
AN:
56614
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00112
AC:
166
AN:
148232
Hom.:
2
Cov.:
20
AF XY:
0.00113
AC XY:
82
AN XY:
72342
show subpopulations
African (AFR)
AF:
0.00335
AC:
131
AN:
39160
American (AMR)
AF:
0.000665
AC:
10
AN:
15040
Ashkenazi Jewish (ASJ)
AF:
0.00290
AC:
10
AN:
3444
East Asian (EAS)
AF:
0.000814
AC:
4
AN:
4914
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4670
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.000119
AC:
8
AN:
67244
Other (OTH)
AF:
0.00145
AC:
3
AN:
2076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000779
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 c.8161+12C>T variant was not identified in the literature. The c.8161+12C>T variant was identified in dbSNP (ID: rs375283810) as “NA” and ADPKD Mutation Database (as likely neutral). The c.8161+12C>T variant was identified in the 1000 Genomes Project in 10 of 5000 chromosomes (frequency: 0.002), NHLBI GO Exome Sequencing Project in 3 of 7768 European American and in 3 of 3774 African American alleles. The variant also was identified in the Exome Aggregation Consortium database (March 14, 2016) in 15 of 18810 chromosomes (freq. 0.0008) in the following populations: European (Non-Finnish) in 8 of 7356 chromosomes (freq. 0.001), African in 5 of 1234 chromosomes (freq. 0.004), South Asian in 1 of 8084 chromosomes (freq. 0.0001), and Other in 1 of 166 chromosomes (freq. 0.006), but was not seen in East Asian, Finnish and Latino populations, increasing the likelihood this could be a low frequency benign variant in some populations. However we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. The c.8161+12C>T variant is located in the 5' splice region but does not affect the invariant +1 and +2 positions. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as likely benign. -

Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PKD1: BS1, BS2 -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:1
Sep 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.33
DANN
Benign
0.83
PhyloP100
-0.67
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375283810; hg19: chr16-2154487; API